Dr Stef Stienstra

Works internationally for several medical and biotech companies as a scientific advisory board member and  also a senior advisor on public health and biodefense for the EU-financed ReSEMBiD project executed by Expertise France;  shareholder of Technofer B.V. in The Netherlands and entrepreneur with 2N3S (Netherlands Network for Safety and Security Systems). Predominantly  in the field of CBRN-defence he is a visiting professor at the University of Rome Tor Vergata and guest lecturer at the NATO school in Oberammergau, Germany;  a renowned CBRN specialist with focus on (micro)biological and chemical threats and  guest lectures all over the world on these topics. Graduated in Medicine and in Biochemistry in The Netherlands with a doctorate and with extensive practical experience in cell biology, immuno-haematology, infectious diseases, biodefense and transfusion medicine. He has 41 peer reviewed scientific publications, over 400 publications in professional literature and is the inventor for three patents.